GSK moves to dismiss Moderna prosecution laches claim in patent dispute
MLex Summary: GlaxoSmithKline filed a response to Moderna's answer and counterclaims in the companies' pair of patent infringement suits, with GSK moving to dismiss Moderna's claims of prosecution laches. GSK sued...To view the full article, register now.
Already a subscriber? Click here to view full article